Kidney Stones Management Market – Global Industry Analysis and Forecast 2023 – 2029

The Kidney Stones Management Market size was valued at USD 1.72 Bn. In 2022 and the total Kidney Stones Management Market revenue is growing by 5.4 % from 2023 to 2029, reaching nearly USD 2.48 Bn.
Kidney Stones Management Market
Kidney stone disease is a crystal concretion formed usually within the kidneys. Increasing urological disorders of human health, affecting about 12% of the world population. It is strongly related to an increased risk of end-stage renal failure this factor significantly boosts the Stones Management Market. The most common type of kidney stone is calcium oxalate formed at Randall's plaque on the renal papillary surfaces. The mechanism of stone formation is a complex process that results from several physicochemical events including supersaturation, nucleation, growth, aggregation, and retention of urinary stone constituents within tubular cells.

This condition affects individuals of all ages and genders. According to an MMR study report, Kidney Stones occur more in males as compared to females between the ages of 20 and 49 years. If patients do not receive proper treatment, they believe that the rate of secondary stone formation recurs at 10-23% per year, 50% in 5-10 years, and 75% in 20 patient-years. However, males have a higher chance of kidney stone recurrence throughout their lifetime, even though more females are experiencing kidney stone incidents. This is why it's important to manage kidney stones through preventive measures. These factors contribute to the growth of the Kidney Stones Management Market.

To know about the Research Methodology :- Request Free Sample Report
Kidney Stones Management Market Dynamics:
The increasing prevalence of kidney stones boosts the market growth

The Kidney Stones Management Market is rising due to the increasing prevalence of kidney stones. The factors related to lifestyle and diet significantly affect Kidney Diseases. Limited physical activity, insufficient hydration, and unhealthy eating habits are causing kidney stones For example, kidney disease affects 37 million people in the United States, and approximately 15% of the adult population experiences issues with kidney stones, additionally, 1 in 3 adults in the U. S., totaling around 80 million individuals, are at risk for kidney disease.

The prevalence of kidney stones rises, therefore, the demand for effective management solutions also increases. This factor drives the growth of the Kidney Stones Management Market. Healthcare providers and patients are searching for advanced treatment options to minimize the symptoms, prevent complications, and improve the overall quality of life. The increasing awareness about kidney stones and the importance of early diagnosis helps to boost the Kidney Stones Management Market.


The rising geriatric population drives the Market Growth

The increasing geriatric population is another significant driving factor for the growth of the Kidney Stones Management Market. The risk of developing kidney stones tends to increase with the growing age. The physiological changes related to aging, such as reduced kidney functionality and decreased urine production, contribute to stone formation. The increasing number of patients with diabetes and hypertension are at increased risk of kidney stones.

This demographic shift leads to a higher demand for Kidney Stone Management Solutions. Older adults need medical intervention for kidney stones due to the potential complications and impact on their overall health. Therefore, healthcare providers are focusing on addressing the specific needs of the geriatric population, including personalized treatment approaches and management strategies, leading to the growth of the Kidney Stones Management Market. The rising number of the elderly population to medical care and the optimization of life expectancy contribute to the growing demand for kidney stone procedures. The expanding geriatric population represents a major driving force behind the growth of the Kidney Stone Management Market.



High-cost associated with treatment restrains the Market growth

The high cost associated with kidney stone treatment and management is a significant restraining factor for the Kidney Stones Management Market. Kidney stone management includes various expenses, such as diagnostic tests, medications, and surgical as well as non-surgical procedures. These costs put a financial burden on patients, particularly for those without adequate insurance coverage and limited budget constraint. The high cost of treatment limits access to care and prevent some patients from seeking timely and appropriate management for their kidney stones. This is especially relevant in cases where individuals limited financial means or face barriers to healthcare affordability. The inability to afford and access necessary treatments result in delayed treatment, which leads to potential complications and poorer outcomes for patients.

Technological innovations and digital health solutions

Technological innovations and digital health solutions create lucrative growth opportunities for the Kidney Stones Management Market. 

Telemedicine and remote monitoring allow healthcare providers to remotely consult with patients, enabling access to specialized care regardless of geographical location. Therefore, Patients receive virtual consultations, discuss symptoms, and receive guidance on managing kidney stones. Remote monitoring technologies track patients' progress, collect relevant data, and provide real-time feedback to healthcare professionals, facilitating proactive management and reducing the need for in-person visits. Digital health platforms and mobile applications offer opportunities to improve patient education, and self-management, and suggest treatment plans. These platforms provide educational resources, dietary guidance, medication reminders, and lifestyle recommendations specific to kidney stone management. Patients track their symptoms, and fluid intake, empowering them to actively participate in their own care.

Technological advancements in imaging modalities, such as ultrasound and computed tomography (CT), accelerate the accuracy and efficiency of diagnosing kidney stones. Ultrasonography is a radiation-free option, while CT scans provide detailed images for precise stone identification and characterization. These technologies aid in early detection, accurate stone sizing, and treatment planning. Technological innovations and digital health solutions have the potential to improve access to care, enhance patient engagement, optimize treatment approaches, and streamline healthcare delivery in the Kidney Stones Management Market

Competitive Analysis:

Kidney Stones Management Market is highly competitive. The key players of the Market include Cook Medical Inc., Boston Scientific Corporation, Olympus Corp., C.R. Bard Inc., Storz Medical AG Richard Wolf GmbH, Lumenis, EDAP TMS, Direx Group Elmed Electronics & Medical Industry & Trade Inc., Medispec Ltd. Convergent Laser Technologies, and M.S. Electro Medical Systems S.A.
The company was founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. Cook Medical is creating effective solutions that benefit millions of patients worldwide. They combine medical devices, drugs, biologic grafts, and cell therapies across more than 16,000 products serving more than 40 medical specialties.

The companies majorly focus on mergers as well as acquisitions and the Product Portfolio. Through strategic partnerships, companies try to expand their business all over the world.
Kidney Stones Management Market Segment Analysis:
Based on Treatment, The Ureteroscopy segment is dominating the treatment segment of the Kidney Stone Management Market in the year 2022. Ureteroscopy is a highly effective and minimally invasive procedure for treating kidney stones. It involves the use of a thin, flexible tube called a ureter scope, which is inserted into the urinary tract to directly visualize and remove or fragment the stones. Ureteroscopy effectively treats stones located in the ureter and kidneys, making it a versatile option. Ureteroscopy is generally considered safe and has a lower risk of complications compared to procedures like open surgery. It is associated with minimal bleeding and a lower chance of infection. Advances in technology and surgical techniques have further enhanced the safety profile of ureteroscopy. Ureteroscopy has a high success rate in removing kidney stones.

The ureter scope allows for precise targeting and removal of stones, minimizing the chances of stone recurrence. Additionally, it combined with other techniques such as laser lithotripsy to break larger stones into smaller fragments, facilitating their removal. Technological advancements in ureteroscopy equipment and techniques. The development of smaller and more flexible ureter scopes, along with improved imaging modalities, is made the procedure more effective and accessible. These advancements have contributed to the increased adoption of ureteroscopy in the treatment of kidney stones.



Based on End-User, the Hospital segment dominates the end-user segment of the Kidney Stone Management Market in the year 2022. Hospitals remain equipped with the infrastructure and specialized facilities required for the diagnosis, procedure, and operation of kidney stones. In addition, the hospitals are well-equipped operating rooms and proper recovery units to perform surgical methods such as ureteroscopy, extracorporeal shock wave lithotripsy, and percutaneous nephrolithotomy.

Hospitals attract trained health experts, including urologists, nephrologists, and specialized nursing staff, who are experienced in the diagnosis and procedure of kidney stones. Hospitals have emergency apartments that remain equipped to handle such situations, providing timely involvement and relief to acutely ill patients involved with kidney stones. For example, According to an MMR study report analysis an estimated 69 thousand public and private hospitals were recorded across India in 2019. Of these, 43 thousand were private-sector hospitals, outnumbering the public sector.


Regional Insight
North America dominates the Global Kidney Stone Management Market in the year 2022. The United States has a highly advanced healthcare system. The country’s strong focus on research and development. The region is home to world-class medical institutions, research centers, and pharmaceutical companies that invest heavily in the development of novel technologies and procedural possibilities for kidney stone removal. This innovation culminated in the introduction of medical devices, minimally invasive surgical techniques, and improved diagnostic tools, which have significantly improved the effectiveness and outcomes of kidney stone treatments.

The increased prevalence of kidney stones creates a substantial market demand for effective management and treatment options. Consequently, healthcare providers in North America have responded to this demand by offering a wide range of specialized services and advanced treatment modalities, attracting patients from both within the region and from around the world. North America benefits from a well-developed healthcare infrastructure. For Example Health care spending, both per person and as a share of GDP, continues far higher in the United States than in other high-income countries. Yet, the U.S. is the only country that doesn’t have universal health coverage.



 
Kidney Stone Management Market Scope: Inquire Before Buying



Global Kidney Stone Management Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 1.72 Bn.


Forecast Period 2023 to 2029 CAGR:
5.4%
Market Size in 2029:
US $ 2.48 Bn.


 Segments Covered:
by Type
Calcium Oxalate
Calcium Phosphate
UricAcid
Struvite
Cysteine


by Diagnostics
Abdominal X-ray
Computed Tomography
Ultrasound
Abdominal MRI
Intravenous Pyelography


by Treatment
Lithotripsy
Ureteroscopy
Percutaneous Nephrolithotomy (PCNL)
Others


by End-User
Hospitals
Specialty Clinics
Ambulatory Surgical Centres



Kidney Stones Management Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Kidney Stones Management Market, Key Players are
1. Cook Medical Inc. (US)
2. Boston Scientific Corporation (US)
3. Olympus Corp. (Japan)
4. C.R. Bard Inc.(US)
5. Storz Medical AG (Switzerland)
6. Richard Wolf GmbH (Germany)
7. Lumenis (Israel)
8. EDAP TMS (France)
9. DirexGroup (Germany)
10. Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
11. Medispec Ltd. (U.S.)
12. Convergent Laser Technologies (U.S.)
13. E.M.S. Electro Medical Systems S.A. (Switzerland)
14. Dornier MedTech GmbH (Germany),
15. Stryker Corp. (U.S.)
16. Olympus Corp. (Japan)
Frequently Asked Questions:
1] What segments are covered in the Global Kidney Stones Management Market report?
Ans. The segments covered in the Kidney Stones Management Market report based on, Type, Diagnostics, Treatment End-user, and Regions.

2] Which region is expected to hold the highest share in the Global Kidney Stones Management Market?
Ans. North America is expected to hold the highest share of the Kidney Stones Management Market.

3] What was the market size of the Global Kidney Stones Management Market by 2022?
Ans. The market size of the Kidney Stones Management Market by 2022 is expected to reach US$ 1.72 Bn.

4] What is the forecast period for the Global Kidney Stones Management Market?
Ans. The forecast period for the Kidney Stones Management Market is 2023-2029.

5] What is the market size of the Global Kidney Stones Management Market in 2029?
Ans. The market size of the Kidney Stones Management Market in 2029 is valued at US$ 2.48 Bn.